Syneron Expects Candela Acquisition To Expand Aesthetics Marketing Reach
This article was originally published in The Gray Sheet
Executive Summary
Syneron Medical aims to extend its global sales reach and obtain new dermatologist and cosmetic surgeon customers through its $65 million purchase of fellow aesthetic device maker Candela
You may also be interested in...
Litigation In Brief
Medtronic v. NuVasive, round one
Litigation In Brief
Medtronic v. NuVasive, round one
People In Brief
CAS Medical Systems CEO: Following the resignation of Andrew E. Kersey as president, CEO and board member, the maker of non-invasive patient-monitoring devices appoints former Wright Medical Group CEO Thomas M. Patton to the same positions Aug. 27. Patton, who was most recently an advisor to private equity group Ferrer Freeman & Co. and CEO of hematology diagnostics start-up QDx, will help CAS Medical Systems commercialize its Fore-Sight Absolute Oximetry technology